| Global spread of carbapenemase-producing Enterobacteriaceae P Nordmann, T Naas, L Poirel Emerging infectious diseases 17 (10), 1791, 2011 | 3156 | 2011 |
| Metallo-β-lactamases: the quiet before the storm? TR Walsh, MA Toleman, L Poirel, P Nordmann Clinical microbiology reviews 18 (2), 306-325, 2005 | 2395 | 2005 |
| The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria P Nordmann, G Cuzon, T Naas The Lancet infectious diseases 9 (4), 228-236, 2009 | 2325 | 2009 |
| Multiplex PCR for detection of acquired carbapenemase genes L Poirel, TR Walsh, V Cuvillier, P Nordmann Diagnostic microbiology and infectious disease 70 (1), 119-123, 2011 | 2185 | 2011 |
| Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases LS Munoz-Price, L Poirel, RA Bonomo, MJ Schwaber, GL Daikos, ... The Lancet infectious diseases 13 (9), 785-796, 2013 | 1979 | 2013 |
| Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology L Poirel, P Nordmann Clinical Microbiology and Infection 12 (9), 826-836, 2006 | 1542 | 2006 |
| Polymyxins: antibacterial activity, susceptibility testing, and resistance mechanisms encoded by plasmids or chromosomes L Poirel, A Jayol, P Nordmann Clinical microbiology reviews 30 (2), 557-596, 2017 | 1494 | 2017 |
| Emergence of Oxacillinase-Mediated Resistance to Imipenem in Klebsiella pneumoniae L Poirel, C Héritier, V Tolün, P Nordmann Antimicrobial agents and chemotherapy 48 (1), 15-22, 2004 | 1425 | 2004 |
| Carbapenem resistance in Enterobacteriaceae: here is the storm! P Nordmann, L Dortet, L Poirel Trends in molecular medicine 18 (5), 263-272, 2012 | 1406 | 2012 |
| CTX-M: changing the face of ESBLs in Europe DM Livermore, R Canton, M Gniadkowski, P Nordmann, GM Rossolini, ... Journal of Antimicrobial Chemotherapy 59 (2), 165-174, 2007 | 1355 | 2007 |
| Emerging carbapenemases in Gram-negative aerobes P Nordmann, L Poirel Clinical Microbiology and Infection 8 (6), 321-331, 2002 | 1205 | 2002 |
| Emergence of Enterobacteriaceae producing extended-spectrum β-lactamases (ESBLs) in the community JDD Pitout, P Nordmann, KB Laupland, L Poirel Journal of antimicrobial chemotherapy 56 (1), 52-59, 2005 | 1164 | 2005 |
| Rapid evolution and spread of carbapenemases among Enterobacteriaceae in Europe R Cantón, M Akóva, Y Carmeli, CG Giske, Y Glupczynski, M Gniadkowski, ... Clinical microbiology and infection 18 (5), 413-431, 2012 | 1146 | 2012 |
| OXA-48-like carbapenemases: the phantom menace L Poirel, A Potron, P Nordmann Journal of Antimicrobial Chemotherapy 67 (7), 1597-1606, 2012 | 1133 | 2012 |
| Comparative Genomics of Multidrug Resistance in Acinetobacter baumannii PE Fournier, D Vallenet, V Barbe, S Audic, H Ogata, L Poirel, H Richet, ... PLoS genetics 2 (1), e7, 2006 | 1111 | 2006 |
| Rapid detection of carbapenemase-producing Enterobacteriaceae P Nordmann, L Poirel, L Dortet Emerging infectious diseases 18 (9), 1503, 2012 | 1024 | 2012 |
| Carbapenemase-producing Klebsiella pneumoniae, a key pathogen set for global nosocomial dominance JDD Pitout, P Nordmann, L Poirel Antimicrobial agents and chemotherapy 59 (10), 5873-5884, 2015 | 980 | 2015 |
| Dissemination of clonally related Escherichia coli strains expressing extended-spectrum β-lactamase CTX-M-15 TM Coque, Â Novais, A Carattoli, L Poirel, J Pitout, L Peixe, F Baquero, ... Emerging infectious diseases 14 (2), 195, 2008 | 975 | 2008 |
| EUCAST expert rules in antimicrobial susceptibility testing R Leclercq, R Cantón, DFJ Brown, CG Giske, P Heisig, AP MacGowan, ... Clinical microbiology and infection 19 (2), 141-160, 2013 | 892 | 2013 |
| Diversity, epidemiology, and genetics of class D β-lactamases L Poirel, T Naas, P Nordmann Antimicrobial agents and chemotherapy 54 (1), 24-38, 2010 | 888 | 2010 |
